Newbridge Financial Services Group, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $262 Million
- Q2 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 141 shares of REGN stock, worth $118,947. This represents 0.06% of its overall portfolio holdings.
Number of Shares
141
Previous 143
1.4%
Holding current value
$118,947
Previous $137,000
8.03%
% of portfolio
0.06%
Previous 0.06%
Shares
15 transactions
Others Institutions Holding REGN
# of Institutions
1,480Shares Held
85.7MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$7.59 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$7.13 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$6.98 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.08 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$3.91 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $90.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...